Mycenax Biotech Intangible Assets

Mycenax Biotech (4726.TWO) currently reports a intangible assets of $19M as of June 2026. That compares with $33M in the prior-year period — down 40.8% year over year. Use the charts on this page to explore Mycenax Biotech's intangible assets history and peer comparisons.

Mycenax Biotech's intangible assets decreased from $33M to $19M — a 40.8% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Mycenax Biotech reported $19M in intangible assets as of June 2026. That compares with $33M in the prior-year period — down 40.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current intangible assets of $19M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Mycenax Biotech, and consider following 4726.TWO for alerts when major investors trade the stock.

Mycenax Biotech is classified in the Healthcare sector. On intangible assets, it currently shows $19M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing 4726.TWO with unrelated industries.